shortagewatch

Home / Olanzapine / Norway

NO ATC N05AH03 · updated 2 Nov 2026

Olanzapine shortage in Norway

Is there an Olanzapine shortage in Norway?

Yes. As of 2 Nov 2026, 7 Olanzapine products are reported short in Norway, the first since 18 Mar 2025. The company estimate for the return is 24 Nov 2026 (latest 1 Sep 2027). Main reason: manufacturing problem.

Also short in Canada, Germany, France, Italy, Spain, Ireland, Austria, Belgium, Czechia, Sweden, New Zealand, Australia. All countries.

Affected products in Norway

CountryProductCompanySinceExpected backReason
NOZypadhera 300 mg pulver og væske til depotinjeksjonsvæske, suspensjon, 3 ml hetteglassCheplapharm Registration Gmbh18 Mar 202515 Jan 2027Manufacturing problem
Produksjonsproblemer (delvis mangel)
NOZypadhera 405 mg pulver og væske til depotinjeksjonsvæske, suspensjon, 3 ml hetteglassCheplapharm Registration Gmbh18 Mar 202515 Jan 2027Manufacturing problem
Produksjonsproblemer (delvis mangel)
NOOlanzapine Viatris 10 mg tablett, filmdrasjert, 56 stk blisterpakningViatris Limited18 Jun 20261 Sep 2027Commercial decision or withdrawal
Kommersielle grunner
NOOlanzapine Viatris 5 mg tablett, filmdrasjert, 28 stk blisterpakningViatris Limited18 Jun 20261 Sep 2027Commercial decision or withdrawal
Kommersielle grunner
NOOlanzapine Viatris 7,5 mg tablett, filmdrasjert, 56 stk blisterpakningViatris Limited18 Jun 20261 Sep 2027Commercial decision or withdrawal
Kommersielle grunner
NOZyprexa 10 mg pulver til injeksjonsvæske, oppløsning, 10 mg hetteglassCHEPLAPHARM Registration GmbH9 Oct 202624 Nov 2026Distribution or logistics
Distribusjonsproblemer
NOZypadhera 210 mg pulver og væske til depotinjeksjonsvæske, suspensjon, 1 sett hetteglass anticipatedCHEPLAPHARM Registration GmbH8 Nov 202613 Dec 2026Manufacturing problem
Produksjonsproblemer (delvis mangel)

Source

DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).